Compound Detail
CHEMBL338892
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
CO[C@H]1C[C@H](C)CC2=C(NCCO)C(=O)C=C(NC(=O)/C(C)=C/CC[C@H](OC)[C@@H](OC(N)=O)/C(C)=C/[C@H](C)[C@H]1O)C2=O
Basic Information
| ChEMBL ID | CHEMBL338892 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | HDOHQMBFWDDFLV-GVAKWLDNSA-N |
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
1
Publications
0
Known Names
Molecular Properties
591.7
MW (Da)
1.57
ALogP
10
HBA
5
HBD
186.5
PSA (Ų)
0.22
QED
1
Ro5 Violations
6
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 1 meas. best 7.47
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| SK-BR-3 CHEMBL613834 | IC50 | 7.47 | 7.47 | 34.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| SK-BR-3 | IC50 | = | 34.0 | nM | 7.47 | Inhibition of oncogene product p185 erbB-2 from human breast cancer cells(SK-BR-... | 7562911 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 7562911 | 10.1021/jm00019a010 | SK-BR-3 | 2 |
Data from ChEMBL 36 via Core Engine